Suchergebnisse - (Person:"Piantoni, Silvia")

PubPharm (7)

1

Reply to : Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al

enthalten in: Clinical and experimental rheumatology | 2021

von Piantoni, S. | Bazzani, C. | Garrafa, E. | +3

CommentOn: Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1142-1143. - PMID 33666163

2

Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2021

von Kumar, R. | Piantoni, S. | Boldini, M. | +7

CommentIn: Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1142-1143. - PMID 33666163

3

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2016

von Piantoni, S. | Colombo, E. | Tincani, A. | +2

4

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

5

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

6

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

7

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2014

von Scarsi, M. | Paolini, L. | Ricotta, D. | +5

CommentIn: J Rheumatol. 2014 May;41(5):825-8. - PMID 24692519

1
[1]